Work

Abstract C14: A novel RAD51 inhibitor, CYT-0851, shows anticancer activity in preclinical models of pancreatic cancer

Year: 2019

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.panca19-c14

Authors: Melinda Day, Jean-Marc Lapierre, Tom O'Shea, Kevin Mills

Institution: Cyteir Therapeutics (United States)

Language: English

Topic: DNA Repair Mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2996452612

Cites:

Cited by: 4

Related to: 10